Report Detail
Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals
- RnM3423206 |
- 15 May, 2019 |
- Global |
- 87 Pages |
- GlobalData |
- Pharma & Healthcare
Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals
Summary
GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in February 2019. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Pharmaceuticals & Healthcare, Global, Deal Summary
- 2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2019
- 2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2019
- 2.2.1 Danaher to Acquire Biopharma Business from General Electric for USD21.4 Billion
- 2.2.2 Takeda Pharma Files Shelf Registration Statement for Public Offering of Hybrid Bonds Due 2079 for USD4.52 Billion
- 2.2.3 Roche to Acquire Spark Therapeutics
- 2.2.4 GlaxoSmithKline and Merck Enter into Co-Development Agreement
- 2.2.5 Abpro and Jiangsu Chia-tai Tianqing Pharma Enter into Development Agreement
- 2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2019
- 2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2019
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
- 3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2019
- 3.1.1 Top M&A Deals in February 2019
- 3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2018 - February 2019
- 3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2019
- 3.2.1 Top Equity Offering Deals in February 2019
- 3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2018 - February 2019
- 3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2019
- 3.3.1 Top PE/VC Deals in February 2019
- 3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2019
- 3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2019
- 3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-February 2019
- 3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-February 2019
- 3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2019
- 3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2018 - February 2019
- 3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2019
- 3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2019
- 3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
- 3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2018 - February 2019
- 3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2018 - February 2019
- 3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2018 - February 2019
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2019
- 4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2019
- 4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2019
- 4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2018 - February 2019
- 4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2018 - February 2019
- 4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2018 - February 2019
- 4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2018 - February 2019
- 4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2019
- 4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2019
- 4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2019
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
- 5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2019
- 5.1.1 Oncology - Deals of the Month
- 5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2019
- 5.2.1 Central Nervous System - Deals of the Month
- 5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2019
- 5.3.1 Infectious Diseases - Deals of the Month
- 5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2019
- 5.4.1 Cardiovascular - Deals of the Month
- 5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2019
- 5.5.1 Immunology - Deal of the Month
- 5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, February 2019
- 5.6.1 Gastrointestinal - Deals of the Month
- 5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, February 2019
- 5.7.1 Metabolic Disorders - Deals of the Month
6 Deal Summary by Geography
- 6.1 Pharmaceuticals & Healthcare, North America Deals, February 2019
- 6.1.1 North America - Deals of the Month
- 6.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2019
- 6.2.1 Europe - Deals of the Month
- 6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2019
- 6.3.1 Asia-Pacific - Deals of the Month
- 6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2019
- 6.4.1 Rest of the World - Deals of the Month
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors
- 7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2018 - February 2019
- 7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2018 - February 2019
8 Further Information
- 8.1 Methodology
- 8.2 About GlobalData
- 8.3 Contact Us
- 8.4 Disclosure information
Summary:
Get latest Market Research Reports on Partnerships, Licensing,. Industry analysis & Market Report on Partnerships, Licensing, is a syndicated market report, published as Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals. It is complete Research Study and Industry Analysis of Partnerships, Licensing, market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
